TJ106
Breast Cancer (pan-HER2)
IND-enablingActive
Key Facts
About Phrontline Biopharma
A Chinese biotech developing innovative bispecific dual-payload ADCs to deliver next-generation frontline cancer therapies.
View full company profileBreast Cancer (pan-HER2)
A Chinese biotech developing innovative bispecific dual-payload ADCs to deliver next-generation frontline cancer therapies.
View full company profile